Anti-Inflammatory Activity of the Marine Cyanobacterium Trichodesmium Erythraeum against Carrageenan-Induced Paw Oedema in Wistar Albino Rats

Abstract

Inflammatory diseases, including rheumatic, diseases are a major cause of morbidity of the working force throughout the world. Inflammation is a tissue reaction to infection. The effects are redness (erythema), swelling (oedema) and pain, to the area that can result in loss of function. Cyanobacteria are photosynthetic prokaryotic organisms which are potentially useful in pharmaceuticals, industrial chemicals, and restriction enzymes. Trichodesmium species are non-heterocystous cyanobacteria, commonly found in tropical and subtropical oligotrophic oceans. They occur in filaments of 20-200 cells which often congregate to form larger colonies called blooms that can be seen and often form dense blooms covering vast areas in sub-tropical regions. The present study tested the anti-inflammatory effect of the marine cyanobacterium, Trichodesmium erythraeum in carrageenan-induced inflammation in rats. The aqueous extract showed anti-inflammatory activity at a high dosage (500 mg/kg) and this effect was on par with the commercial drug, indomethacin. The inhibition of inflammation volume was 57.5±5.5 % and 47.5±4.7% respectively, at higher and lower dosages, in 30 minutes of treatment. The control group without any treatment exhibited an increase in the paw volume. This is the first report on the anti-inflammatory effect of marine-derived Trichodesmium erythraeum.Trichodesmium species are non-heterocystous .cyanobacteria commonly found in tropical and subtropical oligotrophic oceans. They occur in filaments of 20-200 cells which often congregate to form larger colonies called blooms that can be seen and often form dense blooms covering vast areas in sub-tropical regions (1). These organisms are of considerable interest to biological oceanographers because of their reputed ability to fix nitrogen (2). Many studies have proved anti-inflammatory potential of cyanobacterial species (3). Most of these works are restricted to terrestrial organisms, but not in marine species. Since marine organisms thrive in extreme conditions, they should not be ignored in the search for novel metabolites (4). Hence, the present study investigated the anti-inflammatory property of marine cyanobacterial species Trichodesmium erythraeum using an animal model. MATERIALS AND METHODSThe samples of Trichodesmium erythraeum were

Endothelial Cells, Cholesterol, Cytokines, and Aging

“…Vascular endothelial dysfunction occurs during the human aging process and is an independent risk factor for the development of atherosclerosis and hypertension (60)(61)(62)(63)(64)(65). Injury to the vessel wall leads to intimal smooth muscle cell proliferation and luminal occlusion.…”

IL-36 Receptor Antagonist with Special Emphasis on IL-38

“…IL-IFIO mRNA is expressed in several tissue such as heart, placenta, fetal liver, spleen, thymus, and activated B cells of the human tonsil (66)(67)(68)(69)(70). The expression in a variety of immune tissues and similarity to IL-IRa suggest a role of IL-l FlO in the inflammatory response and host defense (52,(71)(72)(73).…”

IL-37 (IL-1F7) the Newest Anti-Inflammatory Cytokine Which Suppresses Immune Responses and Inflammation

“…Interleukins (IL) are cytokines, and are mostly pro-inflammatory proteins that elicit their effects in an autocrine and paracrine manner. IL-4 is a potent anti-inflammatory cytokine that inhibits the synthesis of many inflammatory proteins, including cytokines, thus making IL-4 an attractive target for inhibition of inflammation, and may contribute to the beneficial effects of immunotherapy (15)(16)(17)(18)(19). However, IL-4 induces pro-inflammatory environments by overexpressing a number of pro-inflammatory mediators, such as vascular cell adhesion molecule-l (VCAM-I), E-selectin, monocyte chemoattractant protein-I (MCP-I), and IL-6 in human vascular endothelial cells.…”